Jump to start of content

Fall 2018 Certification and MOC Exams Affected by Hurricane Michael Expand/Collapse the ABIM alert.

ABIM knows that we have many physicians who may be affected by Hurricane Michael. If you live or work in affected areas, we understand that the hurricane may have impacted your ability to take your Fall 2018 Certification or MOC exam as scheduled. We have options to help you get through this process as smoothly as possible. If you have any questions please call us at 1-800-441-ABIM (2246) or email request@abim.org.

Complete requirements by 12/31/18 to avoid a change in certification status Expand/Collapse the ABIM alert.

Sign in to your Physician Portal to view any remaining requirements for the year. Not completing these requirements by 12/31/18 could result in a change to your certification status.

Breadcrumb trail:

Pulmonary Disease Board Exam Committee

Expand All | Collapse All

Peter H. S. Sporn, MD, Chair

Dr. Sporn, a board certified internist, pulmonologist and critical care specialist, is Professor of Medicine and Cell and Molecular Biology at the Feinberg School of Medicine of Northwestern University. He is Program Director of the Northwestern University Pulmonary and Critical Care Fellowship Program, a position he has held since 1996, and since which time he has directed the training of 75 pulmonary and critical fellows.

Since 2010, Dr. Sporn has been a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. His clinical interests include asthma, chronic obstructive pulmonary disease, eosinophilic respiratory diseases, interstitial lung diseases and sarcoidosis. His research interests include the role of eicosanoids in lung inflammation, eosinophil biology, mechanosignaling in lung injury and repair, innate immunity and lung host defense. He has been supported by the National Institutes of Health and the Department of Veterans Affairs throughout his research career.

Dr. Sporn received his undergraduate degree from the University of Chicago and his medical degree from Wayne State University School of Medicine. He trained in internal medicine at Bronx Municipal Hospital Center (now Jacobi Medical Center)/Albert Einstein College of Medicine and in pulmonary and critical medicine at the University of Michigan.

As of January 2017, Dr. Sporn reported the following external relationships:

Work as an author or editor for the following company, with compensation as listed:

  • McGraw-Hill, receiving compensation for authorship of a chapter in Fishman's Pulmonary Diseases and Disorders, Fifth Edition.

David H. Au, MD

Dr. Au is Professor of Medicine at the University of Washington and Director of the Center of Innovation for Veteran-Centered and Value-Driven Care at the VA Puget Sound Health Care System. His work focuses on improving delivery, quality and value of care for patients with chronic lung disease and other complex chronic conditions. In particular, Dr. Au has expertise in interventions targeting the health care system and providers with the goal of improving patient-centered outcomes. He is supported through a number of federal agencies including the Department of Veterans Affairs; the National Heart, Lung and Blood Institute; and the Centers for Disease Control. Dr. Au is board certified in both Pulmonary Disease and Critical Care Medicine.

Dr. Au is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He chairs the Respiratory Measurement Advisory Panel for the National Committee for Quality Assurance. He has held a number of positions within the American Thoracic Society (ATS), including Chair of the International Conference Committee, Behavioral Science and Health Services Research Assembly, and was a member of the ATS Board of Directors. He is a recipient of the Assembly on Behavioral Science and Health Services Research Lifetime Achievement Award. Dr. Au is an active research mentor and is co-Director of the University of Washington Clinical Research Track.

Dr. Au earned both his undergraduate and medical degrees at the University of Chicago, the latter at the Pritzker School of Medicine. He received a master's degree in epidemiology from the University of Washington. Dr. Au completed residency training in internal medicine at the University Hospitals of Cleveland, and Pulmonary and Critical Care Fellowships at the University of Washington. He also completed a health services research and development fellowship at the VA Puget Sound Health Care System.

As of January 2017, Dr. Au reported the following external relationships:

Service on data and safety monitoring boards for the following company, with compensation for travel expenses and honoraria:

  • Novartis

Grant funding from other not-for-profit healthcare-related organizations for staff, paid to the University of Washington:

  • American Lung Association, co-investigator for Airways Clinical Research Centers.

Ellen L. Burnham, MD

Dr. Burnham is an Associate Professor of Medicine in the Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado. She is board certified in Pulmonary Disease and Critical Care Medicine. She is currently Medical Director for the University of Colorado Hospital Medical Intensive Care Unit and Associate Program Director for the Colorado Clinical and Translational Science Institute’s KL2 Program.

Previously, Dr. Burnham conducted National Institute of Health-sponsored research to understand the relationship between alcohol abuse and the development of pulmonary diseases that include pneumonia and the acute respiratory distress syndrome (ARDS). In this capacity, she has been the Principal Investigator for a clinically oriented research resource, known as the Colorado Pulmonary Alcohol Research Collaborative (CoPARC) to support translational research in the field. Additionally, she has served as a co-investigator in multi-center clinical trials testing new therapies for ARDS and sepsis. Dr. Burnham has also been a co-investigator for an NIH-supported mentoring training trial with other Clinical and Translational Science Institutes, and has co-authored a number of papers related to the importance of mentor support for clinical and translational research.

Dr. Burnham is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. She is also an active member of the American Thoracic Society’s (ATS) Assembly on Critical Care, where she has previously served on the Planning Committee and is currently a member of the Programming Committee. She was Chair of the Women in Critical Care working group whose mission has been to improve women’s representation and diversity in the activities of ATS, and in critical care more generally. She is a member of ATS’s Tobacco Action Committee, where her focus is to address the emerging effects of cannabis use on lung health.

Dr. Burnham received biology and chemistry degrees from Texas Christian University, and her medical degree from the University of Texas-Southwestern Medical School. She completed house staff training at the University of Texas-Southwestern Medical School, and her pulmonary/critical care fellowship training at Emory University.

As of October 2017, Dr. Burnham reported the following external relationship:

Dr. Burnham serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American Thoracic Society, Chair of Women in Critical Care, Member of Critical Care Assembly, without compensation.

Funding from not-for-profit healthcare-related organizations, paid to the University of Colorado, from the following organizations:

  • National Institutes of Health, for research related to the effects of alcohol abuse on the lung and for Associate Directorship of KL2 program, receiving funding for expenses, staff and salary support.
  • Thoracic Foundation, for research related to the effects of marijuana use on the lung's immunity and lung physiology, receiving compensation for expenses and staff.

Anne E. Dixon, MA, BM BCh

Dr. Dixon is Director of Pulmonary and Critical Care Medicine at the University of Vermont Larner College of Medicine. She is board certified in Pulmonary Disease and Critical Care Medicine.

Dr. Dixon has been an attending physician in the pulmonary and critical care division at the University of Vermont Medical Center since 2001. She has served on numerous committees for this organization, including serving as a member of the Board of Trustees of the University of Vermont Medical Group. She also leads an active research program in obesity and lung disease at the University of Vermont.

Dr. Dixon is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. She has served on numerous national committees and review boards for the American Thoracic Society, the American Lung Association-Airways Clinical Research Centers, the National Institutes of Health and the Veteran’s Administration.

Dr. Dixon received a degree in natural sciences from the University of Cambridge and her medical degree from Oxford University. She completed residency training at the Johns Hopkins Hospital and fellowship training at the University of Washington.

As of October 2017, Dr. Dixon reported the following external relationship:

Work as an author or editor for following companies, with compensation as listed

  • Humana Press, receiving compensation for authorship on book on obesity and lung disease.

Dr. Dixon serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Association of Pulmonary, Critical Care and Sleep Division Directors, serving as President, without compensation.

Joseph M. Forrester, MD

Dr. Forrester is President of Critical Care and Pulmonary Consultants, P.C. He has held this position, overseeing the pulmonary, critical care and internal medicine hospital care provided at the hospitals serviced by Critical Care and Pulmonary Consultants since 1995. The 85-physician practice provides outpatient and inpatient pulmonary and sleep services, inpatient critical care services, and hospitalist services to five hospitals in the Denver, Colorado metropolitan area. Dr. Forrester is also Director and Director of Hospitalist Services of the Intensive Care Unit at The Medical Center of Aurora.

Dr. Forrester served four years as a physician in the United States Navy, with two years at Bethesda Naval Hospital and the Uniformed Services Medical School. He is a Fellow of the American College of Physicians and the American College of Chest Physicians.

Dr. Forrester is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He is board certified in Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine.

He earned a degree in chemistry from Kalamazoo College and a medical degree with high distinction from Wayne State University. Dr. Forrester completed his internal medicine house staff training and chief residency at The University of Michigan Hospitals and his pulmonary and critical care training at the University of Colorado Health Science Center.

As of January 2017, Dr. Forrester reported no external relationships.

Neil S. Freedman, MD

Dr. Freedman is the Division Head of Pulmonary, Critical Care, Allergy and Immunology at the Northshore University Health System in Evanston, Illinois. He holds the academic rank of Clinical Associate Professor of Medicine at the University of Chicago Pritzker School of Medicine and he is board certified in Pulmonary Disease, Critical Care Medicine and Sleep Medicine. At Northshore, he spends approximately 80% of his time in direct patient care activities with the remainder of his time dedicated to administrative responsibilities. In addition to his clinical and administrative roles, he serves on the Board of Trustees of The Northshore Medical Group Faculty Practice Associates and is Vice President of the Professional Staff.

Previously, Dr. Freedman was in private practice for 12 years as a partner in Pulmonary Physicians of the Northshore in Bannockburn, Illinois.

Dr. Freedman is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He has volunteered for several professional societies in leadership and educational roles. He currently serves as a member American College of Chest Physicians (ACCP) Chest Foundation Board of Trustees, has recently chaired the ACCP sleep network and previously served on the ACCP joint finance oversight and education committees. He has been a member of the ACCP and Associated Professional Sleep Societies scientific program committees and was the chair of the scientific program committee for CHEST Annual meeting in 2016.

Dr. Freedman has delivered more than 250 presentations at national and international meetings on the topics of sleep, pulmonary and critical care medicine. He has chaired post-graduate courses and general sessions at national meetings for several professional societies and recently was the chair of the ACCP Sleep Medicine Board Review Course from 2013 to 2016. He has been recognized for his educational efforts with the Excellence in Education Award from the American Academy of Sleep Medicine in 2016 and the ACCP Distinguished Chest Educator in 2017.

Dr. Freedman received a biology degree from Washington and Jefferson College in Washington, Pennsylvania, and his medical degree at the Mount Sinai School of Medicine in New York. He completed his internship and residency in internal medicine and fellowships in pulmonary, critical care and sleep medicine at the Hospital of the University of Pennsylvania.

As of October 2017, Dr. Freedman reported the following external relationship:

Work as an author or editor for following company, with compensation as listed:

  • UpToDate, receiving compensation for authorship.

Dr. Freedman serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American College of Chest Physicians, Member of Board of Trustees, Faculty Member travel/honoraria, receiving reimbursement for travel expenses and honoraria.
  • American Academy of Sleep Medicine, Faculty Member, receiving reimbursement for travel expenses and honoraria.

Francis X. McCormack, MD

Dr. McCormack, who is board certified in Internal Medicine and Pulmonary Medicine, is Taylor Professor and Director of the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Cincinnati School of Medicine. There, he leads a group of 35 faculty members who care for patients with critical illness, lung cancer, pulmonary hypertension, cystic fibrosis, asthma, chronic obstructive pulmonary disease and interstitial lung diseases. He has an active outpatient and inpatient consultative practice. Dr. McCormack also conducts multicenter, international, investigator-initiated trials, and directs a National Institutes of Health (NIH) funded basic research program focused on the role of the alveolar epithelium in innate immunity, pulmonary fibrosis and rare lung diseases.

Dr. McCormack is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He has served on study sections and committee for the NIH, the Food and Drug Administration, the Department of Veteran Affairs, the Department of Defense, the American Lung Association and the American Thoracic Society. He is a member of the Alpha Omega Alpha Honor Medical Society and the American Society for Clinical Investigation.

Dr. McCormack received a chemistry degree from the University of California, San Diego and his medical degree from the University of Texas Medical Branch. He completed house staff training in internal medicine at the University of Michigan and was a Chief Resident there. He received training in pulmonary and critical care medicine at the University of Colorado and was on faculty there for four years before moving to Cincinnati.

As of January 2017, Dr. McCormack reported the following external relationships:

Service on data and safety monitoring boards for the following companies, with compensation as listed:

  • Takeda Pharmaceutical Co., to oversee a study of namilumab, an antibody against granulocyte macrophage colony-stimulating factor, for psoriasis and rheumatoid arthritis, receiving reimbursement for travel expenses and honoraria.

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with compensation as listed:

  • LAM Therapeutics, advising on potential treatments for lymphangioleiomyomatosis, with hourly compensation paid to the University of Cincinnati.

Post-marketing clinical research, with funding for staff provided to University of Cincinnati, from the following company:

  • Merck, for a clinical trial of a drug for pulmonary fibrosis.

Work as an author or editor for following companies, with compensation as listed:

  • Springer, receiving royalties for textbook chapters.
  • UpToDate, receiving compensation for authorship.

Dr. McCormack holds a patent for a diagnostic test for lymphangioleiomyomatosis, licensed to Vegenics, with royalty income paid to the University of Cincinnati.

Dr. McCormack serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The LAM Foundation, Scientific Director, receiving reimbursement for travel expenses, paid to the University of Cincinnati.
  • Tuberous Sclerosis Alliance, Medical Advisory Board, receiving reimbursement for travel expenses, paid to the University of Cincinnati.

David E. Ost, MD

Dr. Ost is Professor of Medicine at The University of Texas MD Anderson Cancer Center. He is board certified in Pulmonary Disease and Critical Care Medicine. He is Director of Clinical Research in the Department of Pulmonary Medicine.

Dr. Ost joined the Department of Pulmonary Medicine at MD Anderson Cancer Center in 2008. Prior to this he was an Associate Professor at New York University School of Medicine in the Division of Pulmonary and Critical Care Medicine and Director of Interventional Pulmonology from 2005 to 2008. From 1996 to 2005, he was Director of Interventional Pulmonology at North Shore-Long Island Jewish Medical Center.

Dr. Ost is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He has served on the Board of Directors of the American Association for Bronchology and Interventional Pulmonology. He was awarded the Pasquale Ciaglia Memorial Award in Interventional Pulmonology in 2013. He is an associate editor for the Journal of Bronchology and Interventional Pulmonology and the Annals of the American Thoracic Society. He was winner of the Alfred Soffer Research Award in 2006.

Dr. Ost graduated from the Pennsylvania State University with a bachelor's degree in science in 1986. He graduated from Jefferson Medical College in 1990. He completed an internship and residency in Internal medicine at Northwestern University in 1993. He completed a fellowship in pulmonary and critical care medicine at Northwestern University in 1996. He also has a master's degree in public health from the Harvard School of Public Health.

As of January 2017, Dr. Ost reported the following external relationships:

Funding for clinical trial expenses from the following company:

  • Fresh Medical Laboratories, serving as the site principal investigator for a clinical trial of a tool for early detection of lung cancer as an adjunct to lung CT in the evaluation of patients with pulmonary lesions suspicious for lung cancer.

Service on a research-related expert panel or advisory board for the following company, with compensation for honoraria:

  • Vida, for looking at CT imaging data sets to do volumetric measurement of lung nodules and precision imaging for lung cancer surgery.

Work funded by educational grants from industry for staff, paid to MD Anderson Cancer Center, from the following company:

  • Pulmotect, for research on pneumonia in parainfluenza virus.

Work as an author or editor for following company, with compensation as listed:

  • UpToDate, receiving compensation for authorship.

Mindy S. Shapiro, MD

Dr. Shapiro is the Medical Director of the Intensive Care Unit of Kaiser Permanente Santa Rosa Medical Center, Santa Rosa, California, and a practicing pulmonologist in The Physicians Medical Group of Northern California. She is board certified in Internal Medicine, Pulmonary Medicine and Critical Care Medicine.

Dr. Shapiro is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. She has served on the Medical Executive Committees of Sunrise Hospital and Desert Springs Hospital Medical Center in Las Vegas, Nevada. She was the founding Medical Director of IntensiCare Corporation, a hospitalist company based in San Diego, California.

Dr. Shapiro received a bachelor's degree in biology from Radcliffe College, Harvard University. She received her medical degree from Johns Hopkins University School of Medicine. She was a member of the Osler Medical Housestaff Program of the Johns Hopkins Hospital, and she completed her pulmonary and critical care fellowship at Yale University Hospitals.

As of January 2017, Dr. Shapiro reported no external relationships.

James K. Stoller, MD, MS

Dr. Stoller is a pulmonary/critical care physician and Chairman of the Education Institute at the Cleveland Clinic in Ohio. He also serves as a member of the Respiratory Institute at the Cleveland Clinic, where he served previously as the Vice Chairman of Medicine, Head of the Section of Respiratory Therapy, and as Executive Director of Physician Leadership Development. He holds the Jean Wall Bennett Professorship of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and the Samson Global Leadership Academy Endowed Chair and has a secondary appointment as Professor of Organizational Behavior in the Weatherhead School of Management of Case Western Reserve University.

Dr. Stoller’s current clinical research interests focus on chronic obstructive pulmonary disease and especially alpha-1 antitrypsin deficiency and on strategies of care delivery, especially regarding respiratory therapy. He serves as a reviewer and contributor to a number of national and international publications and has authored and edited numerous books, chapters, original peer-reviewed reports, and abstracts.

He currently serves as an Associate Editor for Respiratory Care, as a member of the editorial boards of Clinical Pulmonary Medicine and of Thorax. Dr. Stoller is a Trustee of the American Respiratory Care Foundation and a member of the Board of Directors of the Alpha 1-Foundation. He is also a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He is a Fellow of the American College of Physicians, the American College of Chest Physicians, and the American Association for Respiratory Care.

Dr. Stoller holds a medical degree from Yale University School of Medicine. He completed residency at Peter Bent Brigham Hospital in Boston, Massachusetts and a fellowship in pulmonary medicine at Brigham and Women's Hospital. He also completed a pulmonary medicine fellowship at Yale University School of Medicine and served as a Robert Wood Johnson Clinical Scholar in clinical epidemiology. Additionally, Dr. Stoller completed a fellowship in critical care medicine at the Massachusetts General Hospital. He holds a master's degree in organizational development and analysis from the Weatherhead School of Management at Case Western Reserve University. He is board certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine.

As of May 2017, Dr. Stoller reported the following external relationships:

Service on data and safety monitoring boards for the following companies, with compensation for travel expenses and honoraria:

  • Shire, for a trial of augmentation therapy for alpha-1 antitrypsin.
  • CSL Behring, for a trial of a drug for augmentation therapy of alpha-1 antitrypsin deficiency.
  • Grifols, for a trial of augmentation therapy for alpha-1 antitrypsin deficiency.

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following company, with compensation for travel expenses and honoraria:

  • Arrowhead, for consulting regarding RNA interference for treatment of alpha-1 antitrypsin deficiency.

Work as an author or editor for following companies, with compensation as listed:

  • Elsevier, receiving compensation as an editor for the book, “Egan's Fundamentals of Respiratory Care.”
  • UpToDate, receiving compensation as an editor and author for the COPD section.

Dr. Stoller serves in significant roles with the following organizations, receiving reimbursement for travel as listed:

  • Alpha-1 Foundation, Board of Directors, Medical and Scientific Advisory Committee, receiving reimbursement for travel expenses.
  • American College of Chest Physicians, Education Committee Member, receiving reimbursement for travel expenses.
  • American Respiratory Care Foundation, Board of Directors, receiving reimbursement for travel expenses.
  • COPD Foundation, Medical and Scientific Advisory Committee, receiving reimbursement for travel expenses.

Funding for clinical trial expenses and staff, paid to the Cleveland Clinic, from the following companies:

  • Accreditation Council on Graduate Medical Education, for the Pursuing Excellence Grant to help optimize graduate medical education.
  • American Thoracic Society, for a grant to develop leadership course for American Thoracic Society members.
  • The Doctors Company Foundation, for a grant to extend training to chief residents.
  • CSL Behring, for a trial regarding the consequences of delayed diagnosis of alpha-1 antitrypsin deficiency.
  • National Heart, Lungs, and Blood Institute, for participation in several multicenter trials (Alpha-1 Registry, National Emphysema Treatment Trial, Long-Term Oxygen Treatment Trial).
  • Alpha-1 Foundation, for various studies regarding alpha-1 antitrypsin deficiency.

Dr. Stoller also reported that he has performed phone consultations on various topics in pulmonary medicine organized by Guidepoint Global and by GLG.